FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990389546> ?p ?o ?g. }

• W1990389546 endingPage "e6465" @default.
• W1990389546 startingPage "e6465" @default.
• W1990389546 abstract "Background This study advances the clinical development of the RTS,S/AS01B candidate malaria vaccine to malaria endemic populations. As a primary objective it compares the safety and reactogenicity of RTS,S/AS01B to the more extensively evaluated RTS,S/AS02A vaccine. Methodology A Phase IIb, single centre, double-blind, controlled trial of 6 months duration with a subsequent 6 month single-blind follow-up conducted in Kisumu West District, Kenya between August 2005 and August 2006. 255 healthy adults aged 18 to 35 years were randomized (1∶1∶1) to receive 3 doses of RTS,S/AS02A, RTS,S/AS01B or rabies vaccine (Rabipur®; Chiron Behring GmbH) at months 0, 1, 2. The primary objective was the occurrence of severe (grade 3) solicited or unsolicited general (i.e. systemic) adverse events (AEs) during 7 days follow up after each vaccination. Principal Findings Both candidate vaccines had a good safety profile and were well tolerated. One grade 3 systemic AE occurred within 7 days of vaccination (RTS,S/AS01B group). No unsolicited AEs or SAEs were related to vaccine. A marked increase in anti-CS antibody GMTs was observed post Dose 2 of both RTS,S/AS01B (31.6 EU/mL [95% CI: 23.9 to 41.6]) and RTS,S/AS02A (16.7 EU/mL [95% CI: 12.9 to 21.7]). A further increase was observed post Dose 3 in both the RTS,S/AS01B (41.4 EU/mL [95% CI: 31.7 to 54.2]) and RTS,S/AS02A (21.4 EU/mL [95% CI: 16.0 to 28.7]) groups. Anti-CS antibody GMTs were significantly greater with RTS,S/AS01B compared to RTS,S/AS02A at all time points post Dose 2 and Dose 3. Both candidate vaccines produced strong anti-HBs responses. Vaccine efficacy in the RTS,S/AS01B group was 29.5% (95% CI: −15.4 to 56.9, p = 0.164) and in the RTS,S/AS02A group 31.7% (95% CI: −11.6 to 58.2, p = 0.128). Conclusions Both candidate malaria vaccines were well tolerated over a 12 month surveillance period. A more favorable immunogenicity profile was observed with RTS,S/AS01B than with RTS,S/AS02A. Trial Registration Clinicaltrials.gov NCT00197054" @default.
• W1990389546 created "2016-06-24" @default.
• W1990389546 creator A5013809378 @default.
• W1990389546 creator A5015438763 @default.
• W1990389546 creator A5016959845 @default.
• W1990389546 creator A5019029049 @default.
• W1990389546 creator A5021913918 @default.
• W1990389546 creator A5023513706 @default.
• W1990389546 creator A5025681556 @default.
• W1990389546 creator A5040397859 @default.
• W1990389546 creator A5044909638 @default.
• W1990389546 creator A5057250881 @default.
• W1990389546 creator A5059907819 @default.
• W1990389546 creator A5062217478 @default.
• W1990389546 creator A5069843611 @default.
• W1990389546 creator A5073056741 @default.
• W1990389546 creator A5073714257 @default.
• W1990389546 creator A5077528263 @default.
• W1990389546 creator A5080329476 @default.
• W1990389546 creator A5083056084 @default.
• W1990389546 creator A5088401455 @default.
• W1990389546 creator A5091710844 @default.
• W1990389546 date "2009-07-31" @default.
• W1990389546 modified "2023-10-16" @default.
• W1990389546 title "Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area" @default.
• W1990389546 cites W1989409342 @default.
• W1990389546 cites W2022863293 @default.
• W1990389546 cites W2038910210 @default.
• W1990389546 cites W2046400301 @default.
• W1990389546 cites W2049122105 @default.
• W1990389546 cites W2058916344 @default.
• W1990389546 cites W2063755565 @default.
• W1990389546 cites W2067428749 @default.
• W1990389546 cites W2070633997 @default.
• W1990389546 cites W2071610307 @default.
• W1990389546 cites W2074122062 @default.
• W1990389546 cites W2086004205 @default.
• W1990389546 cites W2100923855 @default.
• W1990389546 cites W2101847661 @default.
• W1990389546 cites W2107181087 @default.
• W1990389546 cites W2124892357 @default.
• W1990389546 cites W2125596172 @default.
• W1990389546 cites W2134881135 @default.
• W1990389546 cites W2139533311 @default.
• W1990389546 cites W2147216872 @default.
• W1990389546 cites W2151784087 @default.
• W1990389546 cites W2155144810 @default.
• W1990389546 cites W2155673357 @default.
• W1990389546 cites W2157427941 @default.
• W1990389546 cites W2163861382 @default.
• W1990389546 cites W2167210100 @default.
• W1990389546 cites W2207867951 @default.
• W1990389546 cites W2340524139 @default.
• W1990389546 cites W4211099777 @default.
• W1990389546 cites W4292199690 @default.
• W1990389546 doi "https://doi.org/10.1371/journal.pone.0006465" @default.
• W1990389546 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2714466" @default.
• W1990389546 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19649245" @default.
• W1990389546 hasPublicationYear "2009" @default.
• W1990389546 type Work @default.
• W1990389546 sameAs 1990389546 @default.
• W1990389546 citedByCount "118" @default.
• W1990389546 countsByYear W19903895462012 @default.
• W1990389546 countsByYear W19903895462013 @default.
• W1990389546 countsByYear W19903895462014 @default.
• W1990389546 countsByYear W19903895462015 @default.
• W1990389546 countsByYear W19903895462016 @default.
• W1990389546 countsByYear W19903895462017 @default.
• W1990389546 countsByYear W19903895462018 @default.
• W1990389546 countsByYear W19903895462019 @default.
• W1990389546 countsByYear W19903895462020 @default.
• W1990389546 countsByYear W19903895462021 @default.
• W1990389546 countsByYear W19903895462022 @default.
• W1990389546 countsByYear W19903895462023 @default.
• W1990389546 crossrefType "journal-article" @default.
• W1990389546 hasAuthorship W1990389546A5013809378 @default.
• W1990389546 hasAuthorship W1990389546A5015438763 @default.
• W1990389546 hasAuthorship W1990389546A5016959845 @default.
• W1990389546 hasAuthorship W1990389546A5019029049 @default.
• W1990389546 hasAuthorship W1990389546A5021913918 @default.
• W1990389546 hasAuthorship W1990389546A5023513706 @default.
• W1990389546 hasAuthorship W1990389546A5025681556 @default.
• W1990389546 hasAuthorship W1990389546A5040397859 @default.
• W1990389546 hasAuthorship W1990389546A5044909638 @default.
• W1990389546 hasAuthorship W1990389546A5057250881 @default.
• W1990389546 hasAuthorship W1990389546A5059907819 @default.
• W1990389546 hasAuthorship W1990389546A5062217478 @default.
• W1990389546 hasAuthorship W1990389546A5069843611 @default.
• W1990389546 hasAuthorship W1990389546A5073056741 @default.
• W1990389546 hasAuthorship W1990389546A5073714257 @default.
• W1990389546 hasAuthorship W1990389546A5077528263 @default.
• W1990389546 hasAuthorship W1990389546A5080329476 @default.
• W1990389546 hasAuthorship W1990389546A5083056084 @default.
• W1990389546 hasAuthorship W1990389546A5088401455 @default.
• W1990389546 hasAuthorship W1990389546A5091710844 @default.
• W1990389546 hasBestOaLocation W19903895461 @default.
• W1990389546 hasConcept C119599485 @default.
• W1990389546 hasConcept C126322002 @default.

• next